Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 13118 | 9.7044 |
09:34 ET | 408 | 9.69 |
09:36 ET | 250 | 9.663 |
09:38 ET | 900 | 9.64 |
09:39 ET | 578 | 9.67 |
09:41 ET | 1000 | 9.67 |
09:43 ET | 200 | 9.72 |
09:45 ET | 1711 | 9.72 |
09:48 ET | 2110 | 9.82 |
09:50 ET | 800 | 9.775 |
09:52 ET | 100 | 9.77 |
09:54 ET | 200 | 9.7701 |
09:56 ET | 1046 | 9.73 |
09:59 ET | 100 | 9.76 |
10:01 ET | 600 | 9.76 |
10:03 ET | 569 | 9.77 |
10:06 ET | 300 | 9.8 |
10:08 ET | 3118 | 9.83 |
10:10 ET | 600 | 9.81 |
10:12 ET | 2415 | 9.77 |
10:14 ET | 200 | 9.75 |
10:15 ET | 300 | 9.74 |
10:17 ET | 300 | 9.75 |
10:19 ET | 300 | 9.74 |
10:21 ET | 442 | 9.74 |
10:24 ET | 1991 | 9.72 |
10:28 ET | 1297 | 9.71 |
10:30 ET | 2294 | 9.685 |
10:32 ET | 1261 | 9.68 |
10:33 ET | 1632 | 9.67 |
10:35 ET | 596 | 9.685 |
10:37 ET | 400 | 9.71 |
10:39 ET | 100 | 9.725 |
10:44 ET | 200 | 9.735 |
10:46 ET | 51608 | 9.74 |
10:48 ET | 3947 | 9.74 |
10:50 ET | 2411 | 9.7 |
10:51 ET | 2014 | 9.68 |
10:53 ET | 1500 | 9.68 |
10:55 ET | 4642 | 9.75 |
10:57 ET | 45705 | 9.71 |
11:00 ET | 7910 | 9.72 |
11:02 ET | 916 | 9.68 |
11:04 ET | 800 | 9.66 |
11:06 ET | 700 | 9.66 |
11:08 ET | 704 | 9.66 |
11:09 ET | 100 | 9.66 |
11:13 ET | 100 | 9.67 |
11:15 ET | 10832 | 9.71 |
11:18 ET | 3186 | 9.6541 |
11:20 ET | 1214 | 9.6 |
11:22 ET | 100 | 9.6 |
11:26 ET | 600 | 9.64 |
11:27 ET | 800 | 9.65 |
11:29 ET | 517 | 9.63 |
11:31 ET | 100 | 9.65 |
11:33 ET | 2196 | 9.6336 |
11:36 ET | 2018 | 9.6288 |
11:38 ET | 800 | 9.65 |
11:40 ET | 900 | 9.63 |
11:42 ET | 200 | 9.62 |
11:44 ET | 3800 | 9.6301 |
11:47 ET | 787 | 9.63 |
11:49 ET | 8949 | 9.63 |
11:51 ET | 600 | 9.64 |
11:54 ET | 200 | 9.64 |
11:56 ET | 1918 | 9.63 |
11:58 ET | 400 | 9.64 |
12:00 ET | 1100 | 9.65 |
12:02 ET | 200 | 9.65 |
12:05 ET | 400 | 9.66 |
12:07 ET | 1200 | 9.69 |
12:09 ET | 1000 | 9.6714 |
12:14 ET | 800 | 9.68 |
12:16 ET | 100 | 9.68 |
12:18 ET | 100 | 9.69 |
12:21 ET | 200 | 9.69 |
12:23 ET | 949 | 9.7 |
12:25 ET | 616 | 9.715 |
12:27 ET | 2309 | 9.72 |
12:30 ET | 2700 | 9.71 |
12:32 ET | 300 | 9.7 |
12:34 ET | 900 | 9.7 |
12:36 ET | 15700 | 9.71 |
12:38 ET | 300 | 9.76 |
12:39 ET | 300 | 9.74 |
12:41 ET | 300 | 9.74 |
12:43 ET | 8488 | 9.755 |
12:45 ET | 100 | 9.77 |
12:48 ET | 500 | 9.77 |
12:50 ET | 2000 | 9.81 |
12:52 ET | 600 | 9.83 |
12:54 ET | 100 | 9.85 |
12:56 ET | 1783 | 9.835 |
12:57 ET | 1708 | 9.85 |
12:59 ET | 2411 | 9.85 |
01:01 ET | 100 | 9.84 |
01:03 ET | 100 | 9.85 |
01:06 ET | 100 | 9.85 |
01:08 ET | 300 | 9.86 |
01:10 ET | 500 | 9.8735 |
01:12 ET | 1852 | 9.875 |
01:15 ET | 2409 | 9.89 |
01:17 ET | 802 | 9.885 |
01:21 ET | 1639 | 9.88 |
01:24 ET | 2100 | 9.88 |
01:26 ET | 700 | 9.8761 |
01:28 ET | 1200 | 9.86 |
01:32 ET | 860 | 9.86 |
01:33 ET | 300 | 9.85 |
01:35 ET | 100 | 9.84 |
01:39 ET | 200 | 9.85 |
01:42 ET | 651 | 9.84 |
01:44 ET | 854 | 9.86 |
01:48 ET | 400 | 9.86 |
01:51 ET | 100 | 9.86 |
01:55 ET | 400 | 9.855 |
01:57 ET | 1884 | 9.84 |
02:00 ET | 989 | 9.84 |
02:02 ET | 100 | 9.84 |
02:08 ET | 198 | 9.84 |
02:09 ET | 3389 | 9.83 |
02:11 ET | 100 | 9.83 |
02:13 ET | 182 | 9.8284 |
02:15 ET | 908 | 9.81 |
02:18 ET | 100 | 9.81 |
02:20 ET | 485 | 9.8 |
02:24 ET | 100 | 9.815 |
02:26 ET | 700 | 9.815 |
02:27 ET | 500 | 9.83 |
02:29 ET | 1200 | 9.82 |
02:31 ET | 200 | 9.83 |
02:33 ET | 300 | 9.82 |
02:36 ET | 1111 | 9.84 |
02:38 ET | 600 | 9.82 |
02:40 ET | 200 | 9.82 |
02:42 ET | 100 | 9.83 |
02:44 ET | 400 | 9.82 |
02:45 ET | 1020 | 9.83 |
02:47 ET | 200 | 9.825 |
02:49 ET | 100 | 9.82 |
02:51 ET | 200 | 9.82 |
02:54 ET | 400 | 9.83 |
02:56 ET | 929 | 9.81 |
02:58 ET | 1457 | 9.83 |
03:00 ET | 200 | 9.82 |
03:02 ET | 1700 | 9.805 |
03:05 ET | 1600 | 9.81 |
03:09 ET | 100 | 9.81 |
03:12 ET | 1363 | 9.815 |
03:14 ET | 200 | 9.815 |
03:16 ET | 520 | 9.825 |
03:18 ET | 2209 | 9.81 |
03:20 ET | 1318 | 9.8 |
03:21 ET | 675 | 9.79 |
03:23 ET | 1650 | 9.785 |
03:25 ET | 733 | 9.775 |
03:27 ET | 1018 | 9.775 |
03:30 ET | 609 | 9.77 |
03:32 ET | 602 | 9.76 |
03:34 ET | 700 | 9.76 |
03:36 ET | 1203 | 9.76 |
03:38 ET | 1209 | 9.755 |
03:39 ET | 1221 | 9.745 |
03:41 ET | 500 | 9.74 |
03:43 ET | 1800 | 9.73 |
03:45 ET | 918 | 9.71 |
03:48 ET | 8014 | 9.66 |
03:50 ET | 4729 | 9.64 |
03:52 ET | 6282 | 9.69 |
03:54 ET | 1340 | 9.705 |
03:56 ET | 4454 | 9.68 |
03:57 ET | 6020 | 9.67 |
03:59 ET | 20651 | 9.69 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.3B | -2.4x | --- |
Prothena Corporation PLC | 1.2B | -7.0x | --- |
Immatics NV | 1.1B | -10.3x | --- |
Gyre Therapeutics Inc | 1.2B | -7.7x | --- |
Silence Therapeutics PLC | 1.1B | -17.9x | --- |
Arcus Biosciences Inc | 1.5B | -5.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 16.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.